| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2104 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1488 | 2006 |
| Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop RF Speck, K Wehrly, EJ Platt, RE Atchison, IF Charo, D Kabat, ... Journal of virology 71 (9), 7136-7139, 1997 | 363 | 1997 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 286 | 2005 |
| Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/− γc−/− mice S Baenziger, R Tussiwand, E Schlaepfer, L Mazzucchelli, ... Proceedings of the National Academy of Sciences 103 (43), 15951-15956, 2006 | 281 | 2006 |
| Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses SY Chan, CJ Empig, FJ Welte, RF Speck, A Schmaljohn, JF Kreisberg, ... Cell 106 (1), 117-126, 2001 | 275 | 2001 |
| Ageing with HIV: medication use and risk for potential drug–drug interactions C Marzolini, D Back, R Weber, H Furrer, M Cavassini, A Calmy, ... Journal of antimicrobial chemotherapy 66 (9), 2107-2111, 2011 | 226 | 2011 |
| Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection PY Bochud, M Hersberger, P Taffé, M Bochud, CM Stein, SD Rodrigues, ... Aids 21 (4), 441-446, 2007 | 216 | 2007 |
| Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections SK Rampini, GV Bloemberg, PM Keller, AC Büchler, G Dollenmaier, ... Clinical Infectious Diseases 53 (12), 1245-1251, 2011 | 205 | 2011 |
| Antigen kinetics determines immune reactivity P Johansen, T Storni, L Rettig, Z Qiu, A Der-Sarkissian, KA Smith, ... Proceedings of the National Academy of Sciences 105 (13), 5189-5194, 2008 | 202 | 2008 |
| Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses SY Chan, RF Speck, MC Ma, MA Goldsmith Journal of virology 74 (10), 4933-4937, 2000 | 190 | 2000 |
| Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology S Baenziger, M Heikenwalder, P Johansen, E Schlaepfer, U Hofer, ... Blood, The Journal of the American Society of Hematology 113 (2), 377-388, 2009 | 180 | 2009 |
| Determinants of HIV-1 broadly neutralizing antibody induction P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ... Nature medicine 22 (11), 1260-1267, 2016 | 176 | 2016 |
| TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection E Schlaepfer, A Audigé, H Joller, RF Speck The Journal of Immunology 176 (5), 2888-2895, 2006 | 166 | 2006 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 142 | 2015 |
| Plasma cell toll‐like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production M Dorner, S Brandt, M Tinguely, F Zucol, JP Bourquin, L Zauner, C Berger, ... Immunology 128 (4), 573-579, 2009 | 134 | 2009 |
| Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1 OT Keppler, FJ Welte, TA Ngo, PS Chin, KS Patton, CL Tsou, NW Abbey, ... The Journal of experimental medicine 195 (6), 719-736, 2002 | 120 | 2002 |
| CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells A Kurioka, C Cosgrove, Y Simoni, B Van Wilgenburg, A Geremia, ... Frontiers in immunology 9, 486, 2018 | 115 | 2018 |
| V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1 SY Chan, RF Speck, C Power, SL Gaffen, B Chesebro, MA Goldsmith Journal of virology 73 (3), 2350-2358, 1999 | 115 | 1999 |
| Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue JC Grivel, ML Penn, DA Eckstein, B Schramm, RF Speck, NW Abbey, ... Journal of virology 74 (11), 5347-5351, 2000 | 103 | 2000 |
